Nova Scotia and Prince Edward Island remain the only provinces who have not yet approved funding for Revlimid. Quebec and Newfoundland & Labrador will only fund Revlimid as a third-line therapy. All other provinces have approved second-line funding. Please click here to view a summary of the updated provincial formulary listings for Revlimid.
Get the PDF version of the myeloma handbook by clicking here...
Myeloma Canada is affiliated with the International Myeloma Foundation, the world's oldest and largest myeloma organization
Myeloma Canada gratefully acknowledges the generous unrestricted educational grants from our website sponsors:
